New study unlocks Tamoxifen's secrets in breast cancer
NCT ID NCT01027416
First seen Apr 22, 2026 · Last updated May 25, 2026 · Updated 6 times
Summary
This study looked at how the hormone therapy tamoxifen affects breast cancer tumors. Researchers examined the interaction between estrogen receptors and a protein called p53 in tumor samples from 59 patients. The goal was to learn more about why some patients respond to tamoxifen, which may help doctors choose better treatments in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
University of Chicago
Chicago, Illinois, 60601, United States
Conditions
Explore the condition pages connected to this study.